QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)

BioMarin Pharmaceutical (BMRN) Insider Trading & Ownership

$87.72
+0.58 (+0.67%)
(As of 03/4/2024 ET)

BioMarin Pharmaceutical (NASDAQ:BMRN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.84%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$15.25 M
Get BMRN Insider Trade Alerts

Want to know when executives and insiders are buying or selling BioMarin Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BMRN Insider Buying and Selling by Quarter


BioMarin Pharmaceutical Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/27/2024Jean Jacques BienaimeDirectorSell1,000$90.35$90,350.00  
2/9/2024Jean Jacques BienaimeDirectorSell15,000$88.28$1,324,200.00  
1/9/2024Jean Jacques BienaimeDirectorSell10,000$98.19$981,900.00  
12/21/2023Jean Jacques BienaimeDirectorSell10,000$93.99$939,900.00  
12/13/2023George Eric DavisEVPSell13,764$95.30$1,311,709.20  
8/16/2023Jeffrey Robert AjerEVPSell5,000$90.00$450,000.00  
8/10/2023Henry J FuchsInsiderSell12,000$90.43$1,085,160.00  
8/8/2023George Eric DavisEVPSell11,000$89.42$983,620.00  
8/7/2023Jean Jacques BienaimeCEOSell4,000$88.10$352,400.00  
5/10/2023Jean Jacques BienaimeCEOSell30,000$94.85$2,845,500.00  
4/10/2023Jean Jacques BienaimeCEOSell10,000$99.56$995,600.00  
4/6/2023Jean Jacques BienaimeCEOSell10,000$96.13$961,300.00  
4/3/2023V Bryan LawlisDirectorSell8,500$97.09$825,265.00  
3/13/2023Jean Jacques BienaimeCEOSell8,000$90.45$723,600.00  
3/10/2023Jean Jacques BienaimeCEOSell15,000$92.28$1,384,200.00  
(Data available from 1/1/2013 forward)












BMRN Insider Trading Activity - Frequently Asked Questions

Who is on BioMarin Pharmaceutical's Insider Roster?
What percentage of BioMarin Pharmaceutical stock is owned by insiders?

1.84% of BioMarin Pharmaceutical stock is owned by insiders. Learn more on BMRN's insider holdings.

Which BioMarin Pharmaceutical insiders have been buying company stock?

The following insider purchased BMRN shares in the last 24 months: Mark J Alles ($314,468.75).

How much insider buying is happening at BioMarin Pharmaceutical?

Insiders have purchased a total of 3,625 BMRN shares in the last 24 months for a total of $314,468.75 bought.

Which BioMarin Pharmaceutical insiders have been selling company stock?

The following insiders have sold BMRN shares in the last 24 months: Brian Mueller ($3,471,434.67), Charles Greg Guyer ($599,154.80), George Eric Davis ($4,692,967.47), Henry J Fuchs ($1,085,160.00), Jean Jacques Bienaime ($22,715,925.00), Jeffrey Robert Ajer ($7,494,835.48), Richard A Meier ($318,345.02), and V Bryan Lawlis ($1,180,820.00).

How much insider selling is happening at BioMarin Pharmaceutical?

Insiders have sold a total of 439,223 BioMarin Pharmaceutical shares in the last 24 months for a total of $41,558,642.44 sold.

Which members of congress are trading BioMarin Pharmaceutical?

Daniel S. Goldman (D-NY) has sold shares of BioMarin Pharmaceutical in the last year totaling $8,000.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:BMRN) was last updated on 3/4/2024 by MarketBeat.com Staff